Anti-angina drugs are the therapeutics used in the treatment of angina pectoris. The condition is the result of myocardial ischemia which occurs due to an imbalance between myocardial blood supply and oxygen requirement. It is the symptom of coronary heart disease in which the arteries carrying blood to the heart become narrow or are blocked due to atherosclerosis.
Several diagnostic tests are performed in order to confirm the condition of angina such as ECG, stress test, echocardiogram, nuclear stress test, chest x-ray, blood tests, coronary angiography, CT scan, cardiac MRI, etc. Anti-angina treatment options include lifestyle changes, medications, angioplasty and stenting, or coronary bypass surgery.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/22891
Segmentations-
By Disease Type
- Stable Angina
- Unstable Angina
- Variant Angina
By Drug Type
- Aspirin
- Nitrates
- Beta Blockers
- Statins
- Calcium Channel Blockers
- Ranolazine
- Angiotensin-converting enzyme (ACE) inhibitors
By Dosage Form Type
- Oral Dosage Forms
- Transdermal
- Injectable
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Drug Stores
- Mail Order Pharmacies
By Region
- North America
- Latin America
- Europe
- Asia Pacific Excluding China
- China
- Middle East & Africa
For the entire list of market players, request for Table of Content here @ https://www.persistencemarketresearch.com/toc/22891
Beta blockers works by blocking the effects of hormone epinephrine (adrenaline) which causes the heart to beat more slowly and with less force, thus reducing the blood pressure. Combining nitrates with β-blockers is most commonly used to block tachycardia and generating synergetic anti-ischaemic effect.
Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/22891
The trends in the development of anti-angina drugs include the use of synergistic combinations, ongoing clinical trials and other pharmacological developments including novel routes of administration, dosing regimen, etc. Further, clinical trials are being done to find out novel compounds for the treatment of angina capable of improving the quality of patients’ life and minimizing the cost of healthcare.
The development of new drugs provides additional therapeutic options in the treatment of stable angina. Increasing competition in the generic version of the medicines is a threat for the market players.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com